Vivani Medical

Novo Nordisk has signed an agreement with Vivani Medical to evaluate NPM-139, a miniature subdermal semaglutide implant designed to deliver medication steadily over extended periods, the companies announced on Monday. The deal marks an effort by the Danish pharmaceutical giant…